These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1700120

  • 1. Immunologic aspects of Kawasaki syndrome.
    Leung DY.
    J Rheumatol Suppl; 1990 Sep; 24():15-8. PubMed ID: 1700120
    [No Abstract] [Full Text] [Related]

  • 2. Kawasaki syndrome: clinical features. Pathophysiology, etiology and therapy.
    Melish ME, Hicks RV.
    J Rheumatol Suppl; 1990 Sep; 24():2-10. PubMed ID: 1700121
    [No Abstract] [Full Text] [Related]

  • 3. [Gamma globulins and Kawasaki disease].
    Musumeci S, Fischer A, Di Dio R.
    Pediatrie; 1986 Jun; 41(4):333-5. PubMed ID: 2433677
    [No Abstract] [Full Text] [Related]

  • 4. [Current clinical and therapeutic aspects of Kawasaki disease].
    Fontaine JL, Tillous-Borde I.
    Ann Pediatr (Paris); 1987 Dec; 34(10):773-5. PubMed ID: 2449115
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of Kawasaki syndrome by intravenous gamma globulins. A medium-term clinical and paraclinical study of 5 cases].
    Lebranchu Y, Despert F, Borderon JC, Bloc D, Renoux M, Bardos P, Laugier J.
    Ann Pediatr (Paris); 1986 Nov; 33(9):809-13. PubMed ID: 3492169
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intravenous immunoglobulin in Kawasaki syndrome: a progress report.
    Melish ME.
    Pediatr Infect Dis; 1986 Nov; 5(3 Suppl):S211-5. PubMed ID: 3487077
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Kawasaki syndrome--cardiovascular manifestations.
    Rose V.
    J Rheumatol Suppl; 1990 Sep; 24():11-4. PubMed ID: 1700119
    [No Abstract] [Full Text] [Related]

  • 12. Kawasaki syndrome: immunomodulatory benefit and potential toxin neutralization by intravenous immune globulin.
    Leung DY.
    Clin Exp Immunol; 1996 May; 104 Suppl 1():49-54. PubMed ID: 8625544
    [Abstract] [Full Text] [Related]

  • 13. [A case of atypical Kawasaki disease].
    Biani D, Malandra L, Gaeta G, Rizzo L.
    Pediatr Med Chir; 1998 May; 20(2):155-6. PubMed ID: 9706642
    [Abstract] [Full Text] [Related]

  • 14. Kawasaki syndrome and the eye.
    Smith LB, Newburger JW, Burns JC.
    Pediatr Infect Dis J; 1989 Feb; 8(2):116-8. PubMed ID: 2468129
    [Abstract] [Full Text] [Related]

  • 15. Kawasaki disease. Some recent studies on pathogenetic mechanisms.
    Tay JS.
    J Singapore Paediatr Soc; 1990 Feb; 32(1-2):11-3. PubMed ID: 1701839
    [Abstract] [Full Text] [Related]

  • 16. Polymorphism of Fc gamma RIIa may affect the efficacy of gamma-globulin therapy in Kawasaki disease.
    Taniuchi S, Masuda M, Teraguchi M, Ikemoto Y, Komiyama Y, Takahashi H, Kino M, Kobayashi Y.
    J Clin Immunol; 2005 Jul; 25(4):309-13. PubMed ID: 16133986
    [Abstract] [Full Text] [Related]

  • 17. [Clinical and therapeutic aspects of Kawasaki disease. Clinical contribution].
    Massimo L, Di Luna F, Sottile R, Fidelini N, Alvano L, De Vita L.
    Pediatr Med Chir; 1987 Jul; 9(5):613-8. PubMed ID: 3441437
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Kawasaki syndrome. Mucocutaneous lymph node syndrome].
    Mezger J, Kroczek RA, Belohradsky BH, Remberger K.
    Med Welt; 1983 Sep 30; 34(39):1085-90. PubMed ID: 6645888
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.